Evidence-Based Guidelines for Aortic Aneurysm & Dissection Repair: A Comprehensive Guide for Patients and Professionals

Evidence-Based Guidelines for Aortic Aneurysm & Dissection Repair: A Comprehensive Guide for Patients and Professionals

**Disclaimer:** This article is intended for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.

1. Introduction to Aortic Aneurysms and Dissections

The aorta, the body's largest artery, plays a pivotal role in circulating oxygenated blood from the heart to the rest of the body. Conditions affecting the aorta, such as **aortic aneurysms** and **aortic dissections**, represent significant cardiovascular challenges with potentially life-threatening consequences. An aortic aneurysm is characterized by a localized, abnormal dilation of the aorta, while an aortic dissection involves a tear in the inner layer of the aortic wall, leading to blood flowing between the layers and causing them to separate [1]. These conditions necessitate precise diagnostic approaches and timely, evidence-based management strategies to optimize patient outcomes. The development and adherence to comprehensive guidelines are crucial for standardizing care, improving clinical decision-making, and ultimately enhancing the prognosis for individuals affected by aortic disease. This guide aims to provide an overview of the current evidence-based guidelines for the repair and treatment of aortic aneurysms and dissections, targeting both patients seeking to understand their condition and healthcare professionals aiming to refine their practice. INVAMED is committed to supporting healthcare professionals with advanced medical devices that align with these critical guidelines.

2. Understanding Aortic Anatomy and Disease Classification

To comprehend aortic pathologies, a foundational understanding of normal aortic anatomy is essential. The aorta originates from the left ventricle of the heart, ascending through the chest (ascending aorta), arching over the heart (aortic arch), and then descending through the chest (descending thoracic aorta) and abdomen (abdominal aorta) before branching into smaller arteries. Dilation of the aorta is generally defined as an aortic diameter of ≥4.0 cm, with the risk of dissection significantly increasing when the diameter reaches ≥4.5 cm [1].

**Acute Aortic Syndromes (AAS)** encompass a spectrum of critical conditions, including:

• **Aortic Dissection:** A tear in the intimal layer allows blood to enter the media, creating a false lumen.
• **Intramural Hematoma (IMH):** Hemorrhage within the aortic wall without an intimal tear.
• **Penetrating Aortic Ulcer (PAU):** Ulceration of an atherosclerotic plaque that penetrates the internal elastic lamina into the media.

Aortic dissections are further classified using two primary systems [1]:

• **DeBakey Classification:**
• **Type I:** Originates in the ascending aorta and extends to the arch and descending aorta.
• **Type II:** Limited to the ascending aorta.
• **Type IIIa:** Limited to the descending aorta.
• **Type IIIb:** Originates in the descending aorta and extends to the distal branches.

• **Stanford Classification:**
• **Type A:** Involves the ascending aorta (DeBakey Types I and II).
• **Type B:** Does not involve the ascending aorta (DeBakey Type III).

3. Diagnostic Modalities and Measurements

Accurate diagnosis and consistent surveillance are paramount in managing aortic disease. Reproducible aortic measurements are critical for monitoring disease progression and determining the timing of intervention. Clinicians are advised to minimize ionizing radiation exposure during surveillance imaging [1].

Key imaging techniques include [1]:

• **Transthoracic Echocardiography (TTE):** Used for aortic root measurements, typically captured during end-diastole from leading edge to leading edge.
• **Computed Tomography (CT) and Magnetic Resonance Imaging (MRI):** These modalities are used for comprehensive aortic assessment. Aortic root and ascending aortic dimensions should be measured from inner edge to inner edge using electrocardiographic gating. Multiple measurements from sinus to sinus are recommended to obtain the maximum diameter.

**Screening for Abdominal Aortic Aneurysm (AAA):** All men and women aged 65 or older with a history of smoking or a first-degree relative diagnosed with AAA should undergo an abdominal ultrasound for screening [1]. Surveillance imaging for both thoracic and abdominal aortic aneurysms is guided by aortic diameters and growth rates. Gated chest CT is the preferred initial imaging modality for assessing acute aortic syndrome.

4. Genetic Evaluation and Family Screening

A significant proportion of aortic diseases, particularly thoracic aortic aneurysms and dissections, have a genetic component. A thorough multigenerational family history is indicated for patients with aortic root or ascending aorta aneurysms or aortic dissection [1].

**Genetic Testing and Screening Recommendations:**

• Patients at risk for hereditary thoracic aortic disease should undergo genetic testing for known aortopathy genes.
• For patients with aneurysms of the aortic root or ascending aorta or those with aortic dissection, screening of first-degree relatives with aortic imaging is recommended.
• If a pathogenic variant for thoracic aortic disease is identified, cascade genetic testing should be offered to family members.
• For patients with a bicuspid aortic valve and a dilated aortic root, screening of all first-degree relatives with transesophageal echocardiography (TEE), CT, or MRI is recommended [1].

5. Aortic Disease in Special Populations

Certain populations face unique considerations in the management of aortic disease due to genetic predispositions or physiological states.

• **Heritable Thoracic Aortic Disease (HTAD):** Surgical thresholds for prophylactic surgery in nonsyndromic HTAD are influenced by genetic variants and additional risk factors like age, family history, and aortic diameter. For instance, patients with ACTA2 mutations may experience dissection at diameters <4.5 cm [1].

• **Marfan Syndrome:** Patients with Marfan syndrome require initial TTE at diagnosis to measure aortic root and ascending aortic diameters, followed by another TTE six months later to monitor growth rate. Annual surveillance imaging with TTE, CT, or MRI is indicated. Medical therapy with maximally tolerated β-blockers or angiotensin receptor blockers is recommended to reduce aortic dilation [1].

• **Loeys-Dietz Syndrome:** Similar to Marfan syndrome, initial and follow-up TTEs are crucial. Additionally, a CT or MRI from head to pelvis should be performed to screen the entire aorta and its branches for aneurysms, dilation, or tortuosity [1].

• **Turner Syndrome:** A screening TTE and MRI are recommended at diagnosis to detect aortic dilation, bicuspid aortic valve, aortic coarctation, and other congenital heart defects. Follow-up imaging is indicated every 5 years in children and every 10 years in adults [1].

• **Pregnancy and Aortopathy:** Women with aortopathy are at an elevated risk for aortic dissection during pregnancy, particularly in the third trimester and early postpartum period due to physiological changes. Aortic surveillance imaging throughout pregnancy and several weeks postpartum is indicated. Peripartum management requires a multidisciplinary team, with cardiothoracic surgery available for urgent intervention [1].

6. Surgical Thresholds and Intervention Strategies

Decisions regarding surgical intervention are complex and depend on various factors, including aneurysm size, growth rate, patient symptoms, and underlying genetic conditions. The goal is to prevent rupture or dissection while minimizing surgical risks.

**General Surgical Thresholds for Aneurysms [1]:**

• **Sporadic and Bicuspid Aortic Valve-Related Aortic Root and Ascending Aortic Aneurysms:** Surgical intervention is typically recommended for diameters ≥5.5 cm at most centers, or ≥5.0 cm at experienced centers with a multidisciplinary aortic team.
• **Rapid Growth:** Consideration for surgery is given if the growth rate is ≥0.3 cm/year over two consecutive years, or ≥0.5 cm/year in one year for those with heritable thoracic aortic disease or bicuspid aortic valve.
• **Marfan Syndrome and Heritable Thoracic Aortic Disease:** For asymptomatic patients, thresholds are generally ≥5.0 cm at most centers, or ≥4.5 cm with a high risk of aortic dissection at experienced centers. Earlier surgery may be indicated for rapid growth, family history of dissection, desire for pregnancy, or severe valve regurgitation.
• **Loeys-Dietz Syndrome:** Surgical thresholds vary based on genetic variant, aortic diameter, growth rate, age, sex, and family history. Intervention may be recommended at smaller diameters, especially for TGFBR1 and TGFBR2 variants with associated high-risk characteristics.
• **Turner Syndrome:** For asymptomatic patients aged 15 or older, the threshold for surgical intervention is >2.5 cm/m² (aortic size index).
• **Descending Thoracoabdominal Aneurysms:** Surgical intervention is typically recommended for diameters ≥6 cm.
• **Abdominal Aortic Aneurysms (AAA):** Thresholds are ≥5.5 cm for men and ≥5.0 cm for women.

Prophylactic surgery is also reasonable when the maximal cross-sectional area (cm²) of the root or ascending aorta divided by height (m) is ≥10 cm²/m [1].

7. Medical Therapy for Aortic Disease

Medical management plays a crucial role in slowing disease progression, controlling symptoms, and preparing patients for intervention.

**Pharmacological Management [1]:**

• **Beta-blockers and Angiotensin Receptor Blockers (ARBs):** Used as antihypertensives for patients with thoracic aortic aneurysm and hypertension. They help reduce aortic wall stress.
• **Statins and Low-dose Aspirin:** Reasonable for patients with atherosclerotic thoracic or abdominal aortic aneurysms.
• **Smoking Cessation:** Strongly recommended for all patients with aortic aneurysms due to its significant impact on disease progression.
• **Acute Aortic Syndromes:** Patients require immediate blood pressure-lowering therapy, typically with intravenous (IV) β-blockers as first-line agents, followed by IV vasodilators as second-line agents.

8. Surgical Management Approaches

The choice between open surgical repair and endovascular techniques depends on the specific aortic pathology, patient characteristics, and anatomical considerations.

• **Open Surgical Intervention:** Recommended for aortic root, ascending aortic, and aortic arch aneurysms, with or without aortic valve involvement. It is also considered reasonable for patients with connective tissue disorders, hereditary thoracic aortic aneurysm and dissection, or those with a longer life expectancy (>10 years) [1].

• **Endovascular Repair (TEVAR/EVAR):** For patients with thoracic descending aortic and abdominal aortic aneurysms, endovascular repair is preferred over open surgical repair if the anatomy is favorable. This less invasive approach involves deploying a stent-graft within the aorta to reinforce the weakened segment [1].

• **Management of Acute Aortic Dissections [1]:**
• **Acute Type A Aortic Dissections:** Require emergent open surgical repair, often involving aortic valve suspension or replacement depending on aortic root involvement.
• **Uncomplicated Acute Type B Aortic Dissections:** Primarily managed medically. Endovascular stenting may be considered for high-risk characteristics.
• **Complicated Acute Type B Aortic Dissections:** (e.g., rupture, branch artery occlusion, malperfusion) typically undergo endovascular stenting over surgical repair if anatomy is favorable.

• **Repair of Intramural Hematoma (IMH) and Penetrating Aortic Ulcers (PAU) [1]:**
• Urgent surgical repair is recommended for Type A IMH and complicated Type B IMH. Medical management is preferred for uncomplicated Type B IMH.
• Urgent surgical repair is also indicated for PAUs of the ascending aorta, aortic rupture, or persistent pain from isolated PAUs.

• **Blunt Traumatic Aortic Injury:** The choice between open or endovascular repair for descending or abdominal blunt traumatic aortic injury depends on the patient's clinical status, hospital resources, and clinician experience [1].

9. Conclusion

The management of aortic aneurysms and dissections is a dynamic field, continuously evolving with advancements in diagnostic imaging, medical therapies, and surgical techniques. Adherence to evidence-based guidelines, such as those provided by the ACC/AHA, is fundamental to ensuring optimal patient care. A multidisciplinary approach, involving cardiologists, cardiac surgeons, vascular surgeons, geneticists, and other specialists, is crucial for individualized treatment planning and long-term surveillance. As medical device manufacturers, INVAMED is dedicated to innovating solutions that support these guidelines, ultimately contributing to improved outcomes for patients worldwide. Continued research and collaboration are essential to further refine these guidelines and address existing evidence gaps, paving the way for even more effective treatments in the future.

10. References

[1] Hussain, K., & Huerter, M. (2024). ACC/AHA Guidelines for Aortic Disease. *StatPearls [Internet]*. National Center for Biotechnology Information. [https://www.ncbi.nlm.nih.gov/books/NBK606128/](https://www.ncbi.nlm.nih.gov/books/NBK606128/)